[分子药物鉴定修订:在三十年后绘制了一个新的路线]
Lu-Qi Huang1, Han Zheng1, Yuan Yuan1
1State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, China Academy of Chinese Medical Sciences Beijing 100700, China.
概括
在过去的30年里,分子药理学已经取得了重大进展,为原始药物识别和资源节约制定了标准. 未来与AI和omics的整合有望为中国传统医学的现代化提供预测和设计方法.
科学领域:
- 分子药理学是指分子药理学.
- 跨学科科学 跨学科科学
- 传统中国医学 (TCM) 的现代化和现代化.
背景情况:
- 分子药物鉴定 (Molecular Pharmacognosy) 起源于1995年,在过去的30年里,它发展成为一个成熟的跨学科领域.
- 该学科的特点是全面的理论系统,先进的方法和广泛的工业应用.
研究的目的:
- 系统地审查分子药理学理论创新,技术标准化,工业应用和平台建设的里程碑.
- 阐明进化研究范式,分析当前的挑战和未来的方向.
主要方法:
- 对理论进步和技术标准化的系统审查.
- 分析分子识别,道迪草药机制,资源保护和化合物生物合成方面的突破性成就.
- 在学科的研究范式中探索理论和实践之间的相互作用.
主要成果:
- 重要的里程碑包括用于原始药物分子识别和阐明道迪草药形成的技术标准.
- 在稀有资源的保护模型和活性化合物的生物合成方面取得了突破.
- 研究范式通过问题导出,假设,技术创新和理论丰富的循环进步.
结论:
- 分子药理识别在精确识别,地理真实性机制和可持续资源利用方面面临挑战.
- 与人工智能,泛经济学,量子计算和基因编辑的整合将将范式转移到预测和设计.
- 这种整合将推动TCM现代化的精度,系统化和工程的新阶段.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
61
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
61
Pharmacogenetics and Pharmacogenomics: Overview
109
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
109
Pharmacodynamics: Overview and Principles
3.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.8K
Drug Discovery: Overview
12.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.6K
Biopharmaceutics and Pharmacokinetics: Overview
4.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.8K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
83
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
83


